CHIKA ACHEBE: Open Payments
NPI 1225454275 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 53 payments from 14 companies in 2025. Trend: 2023 $1,813 · 2024 $1,716 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $358 |
| ABBVIE INC. | 9 | $320 |
| Alkermes, Inc. | 9 | $233 |
| Axsome Therapeutics, Inc. | 5 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, Auvelity, TRINTELLIX, AUSTEDO XR, INGREZZA, FANAPT.
Industry payments across CO — which companies pay providers there.
